158 related articles for article (PubMed ID: 12597640)
21. Past and present concepts in flow cytometry: a European perspective.
Valet G
J Biol Regul Homeost Agents; 2003; 17(3):213-22. PubMed ID: 14524606
[TBL] [Abstract][Full Text] [Related]
22. A survey of current practices in clinical flow cytometry.
McCoy JP; Overton WR
Am J Clin Pathol; 1996 Jul; 106(1):82-6. PubMed ID: 8701938
[TBL] [Abstract][Full Text] [Related]
23. Flow cytometric immunophenotyping of acute lymphoblastic leukemia: is the time ready for consensus the guidelines?
Basso G; Lanza F; Orfao A; Benè M; Borowitz M; Campana D; Lacombe F; Ludwig WD; Porwitt-MacDonald A; Rothe G; Dworzac M;
J Biol Regul Homeost Agents; 2002; 16(4):257-8. PubMed ID: 12597641
[No Abstract] [Full Text] [Related]
24. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: medical indications.
Davis BH; Foucar K; Szczarkowski W; Ball E; Witzig T; Foon KA; Wells D; Kotylo P; Johnson R; Hanson C; Bessman D
Cytometry; 1997 Oct; 30(5):249-63. PubMed ID: 9383099
[No Abstract] [Full Text] [Related]
25. Composition of the International Bioethics Committee of UNESCO (IBC).
UNESCO
J Int Bioethique; 2002; 13(3-4):167-71. PubMed ID: 12747353
[No Abstract] [Full Text] [Related]
26. Standardized Multi-Color Flow Cytometry and Computational Biomarker Discovery.
Schlickeiser S; Streitz M; Sawitzki B
Methods Mol Biol; 2016; 1371():225-38. PubMed ID: 26530805
[TBL] [Abstract][Full Text] [Related]
27. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data reporting.
Braylan RC; Atwater SK; Diamond L; Hassett JM; Johnson M; Kidd PG; Leith C; Nguyen D
Cytometry; 1997 Oct; 30(5):245-8. PubMed ID: 9383098
[No Abstract] [Full Text] [Related]
28. Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA).
Escribano L; Diaz-Agustin B; López A; Núñez López R; García-Montero A; Almeida J; Prados A; Angulo M; Herrero S; Orfao A;
Cytometry B Clin Cytom; 2004 Mar; 58(1):1-8. PubMed ID: 14994369
[TBL] [Abstract][Full Text] [Related]
29. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: recommendations for training and education to perform clinical flow cytometry.
Greig B; Oldaker T; Warzynski M; Wood B
Cytometry B Clin Cytom; 2007; 72 Suppl 1():S23-33. PubMed ID: 17803190
[TBL] [Abstract][Full Text] [Related]
30. Reply to van der Sluijs-Gelling et al.
Gaipa G; Basso G; Ratei R; Biondi A; Dworzak M
Leukemia; 2005 Dec; 19(12):2351-2. PubMed ID: 16304578
[No Abstract] [Full Text] [Related]
31. Quality Control of Immunophenotyping.
Greig B
Methods Mol Biol; 2019; 2032():227-279. PubMed ID: 31522423
[TBL] [Abstract][Full Text] [Related]
32. Global summit of national bioethics commissions: Tokyo communique (1999).
Japan. National Bioethics Commission
J Int Bioethique; 2001 Jun; 12(2):85-7. PubMed ID: 12747350
[No Abstract] [Full Text] [Related]
33. 2006 Bethesda International Consensus Conference on Flow Cytometric Immunophenotyping of Hematolymphoid Neoplasia.
Stetler-Stevenson M; Davis B; Wood B; Braylan R
Cytometry B Clin Cytom; 2007; 72 Suppl 1():S3. PubMed ID: 17630651
[No Abstract] [Full Text] [Related]
34. Ethics support in clinical practice in Europe: Croatia.
Vrhovac B
Med Etika Bioet; 2005; 11(Suppl.):14-5. PubMed ID: 16607720
[No Abstract] [Full Text] [Related]
35. Facts and indicators on palliative care development in 52 countries of the WHO European region: results of an EAPC Task Force.
Centeno C; Clark D; Lynch T; Racafort J; Praill D; De Lima L; Greenwood A; Flores LA; Brasch S; Giordano A;
Palliat Med; 2007 Sep; 21(6):463-71. PubMed ID: 17846085
[TBL] [Abstract][Full Text] [Related]
36. International consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia.
Wilson WH
Cytometry B Clin Cytom; 2007; 72 Suppl 1():S2. PubMed ID: 17803186
[No Abstract] [Full Text] [Related]
37. Impact of standardization on clinical cell analysis by flow cytometry.
Keeney M; Barnett D; Gratama JW
J Biol Regul Homeost Agents; 2004; 18(3-4):305-12. PubMed ID: 15786697
[TBL] [Abstract][Full Text] [Related]
38. Ethics support in clinical practice in Europe: Russian Federation.
Tischenko P
Med Etika Bioet; 2005; 11(Suppl.):18-9. PubMed ID: 16607726
[No Abstract] [Full Text] [Related]
39. Ethics support in clinical practice in Europe: Estonia.
Talvik T
Med Etika Bioet; 2005; 11(Suppl.):15-6. PubMed ID: 16607722
[No Abstract] [Full Text] [Related]
40. Diagnostic and prognostic value of flow cytometric immunophenotyping in malignant hematological diseases.
Chianese R; Brando B; Gratama JW;
J Biol Regul Homeost Agents; 2002; 16(4):259-69. PubMed ID: 12597642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
